LSIPR 50 2018: It’s not like selling cars
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR.
Latest news
FDA grants Teva approval for first EpiPen generic
17-08-2018
The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.
Purdue and Amneal OxyContin clash ends
15-08-2018
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Robert DeBerardine 16-08-2018
- LSIPR 50 2018: Padmanabh Bhatt 15-08-2018
Regions
- LSIPR 50 2018: Robert DeBerardine 16-08-2018
- LSIPR 50 2018: Padmanabh Bhatt 15-08-2018
Sectors
- LSIPR 50 2018: Padmanabh Bhatt 15-08-2018
- Combination SPCs: shaken and stirred 14-08-2018
